Trinity Biotech (TRIB) Share-based Compensation Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) Share-based Compensation Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 7.56% |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 113.88% |
| Sep 30, 2024 | -66.12% |
| Jun 30, 2024 | -88.31% |
| Dec 31, 2023 | -176.56% |
| Sep 30, 2023 | -99.38% |
| Jun 30, 2023 | 699.18% |
| Dec 31, 2022 | 755.84% |
| Jun 30, 2022 | -60.90% |
| Dec 31, 2016 | -9.74% |
| Dec 31, 2015 | -26.12% |
| Dec 31, 2012 | 90.71% |
| Dec 31, 2011 | 11.49% |
| Dec 31, 2010 | 67.06% |